Viewing Study NCT01681992

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:39 PM
Ignite Modification Date: 2026-02-12 @ 6:02 AM
Study NCT ID: NCT01681992
Status: COMPLETED
Last Update Posted: 2021-01-07
First Post: 2012-09-06
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of Life
Sponsor: GlaxoSmithKline
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Measles View
None Mumps View
None Rubella View
None Measles-Mumps-Rubella Vaccine View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Safety View
None Measles, mumps and rubella diseases View
None Immunogenicity View